The Efficacy Study of Sodium Hyaluronate to Treat Symptomatic Hip Osteoarthritis
Status:
Terminated
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
To demonstrate the difference in terms of symptomatic efficacy between ADANT® sodium
hyaluronate and placebo following an intra-articular injection in patients with symptomatic
osteoarthritis of the hip.
Each patient will receive an injection of sodium hyaluronate or placebo in the symptomatic
hip and will be followed up for three months.
At the third month, if the score for overall pain is still > 40 mm on the VAS, a second
injection of ADANT® can be given irrespective of which treatment was received previously. The
patient will be followed up for a further 3 months in an open-label fashion (monthly visits).